Research progress and medication nursing of luspatercept in the treatment of β-thalassemia

WAN Zhiliu; RAO Jie

doi:10.12102/j.issn.2095-8668.2025.24.009

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Research progress and medication nursing of luspatercept in the treatment of β-thalassemia

DOI: 10.12102/j.issn.2095-8668.2025.24.009

Research progress and medication nursing of luspatercept in the treatment of β-thalassemia

WAN Zhiliu

RAO Jie

Abstract：This review summarizes the mechanism of action, efficacy, and safety of luspatercept, as well as its administration nursing, medication precautions, adverse reaction nursing, and health guidance in the treatment of beta-thalassemia, aiming to provide a theoretical basis for clinical practice.

Keywords：luspaterceptβ-thalassemianursingreview

Publication Date：2025-12-25

Online Publishing Date：2025-12-31(First online date of this platform, not the publication date of the document)

Pages：5( 5067-5071 )

Chinese Evidence-based Nursing

ISSN：2095-8668

Year, Vol.(Issue)：2025,11(24)